BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang H, Zhu Y, Sun C, Xie Y, Adu-frimpong M, Deng W, Yu J, Xu X, Han Z, Qi G. GSH responsive nanomedicines self-assembled from small molecule prodrug alleviate the toxicity of cardiac glycosides as potent cancer drugs. International Journal of Pharmaceutics 2020;575:118980. [DOI: 10.1016/j.ijpharm.2019.118980] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Wei S, Zhang Y, Pan A, Adu-Frimpong M, Sun C, Qi G. Improving cellular uptake and bioavailability of periplocymarin-linoleic acid prodrug by combining PEGylated liposome. Drug Deliv 2022;29:2491-7. [PMID: 35912819 DOI: 10.1080/10717544.2022.2104406] [Reference Citation Analysis]
2 Lang X, Yu Q, Li H, Luo Y, Yu X, Wang H, Wang M. Identification of a non-planar imidazole-cored small molecule for selective telomeric G4 DNA targeting. Dyes and Pigments 2022;197:109901. [DOI: 10.1016/j.dyepig.2021.109901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Luo K, Gao Y, Yin S, Yao Y, Yu H, Wang G, Li J. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer. Acta Biomater 2021;134:649-63. [PMID: 34289420 DOI: 10.1016/j.actbio.2021.07.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
4 Zhao F, Hu K, Shao C, Jin G. Original boron cluster covalent with poly-zwitterionic BODIPYs for boron neutron capture therapy agent. Polymer Testing 2021;100:107269. [DOI: 10.1016/j.polymertesting.2021.107269] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Xu C, Yang H, Xiao Z, Zhang T, Guan Z, Chen J, Lai H, Xu X, Huang Y, Huang Z, Zhao C. Reduction-responsive dehydroepiandrosterone prodrug nanoparticles loaded with camptothecin for cancer therapy by enhancing oxidation therapy and cell replication inhibition. Int J Pharm 2021;603:120671. [PMID: 33961957 DOI: 10.1016/j.ijpharm.2021.120671] [Reference Citation Analysis]
6 Bhat M, Jatyan R, Mittal A, Mahato RI, Chitkara D. Opportunities and challenges of fatty acid conjugated therapeutics. Chem Phys Lipids 2021;236:105053. [PMID: 33484709 DOI: 10.1016/j.chemphyslip.2021.105053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hou C, Ma N, Shen Z, Chi G, Chao S, Pei Y, Chen L, Lu Y, Pei Z. A GSH-Responsive Nanoprodrug System Based on Self-Assembly of Lactose Modified Camptothecin for Targeted Drug Delivery and Combination Chemotherapy. Int J Nanomedicine 2020;15:10417-24. [PMID: 33376329 DOI: 10.2147/IJN.S276470] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 He Z, Jiang H, Zhang X, Zhang H, Cui Z, Sun L, Li H, Qian J, Ma J, Huang J. Nano-delivery vehicle based on chlorin E6, photodynamic therapy, doxorubicin chemotherapy provides targeted treatment of HER-2 negative, ανβ3-positive breast cancer. Pharmacol Res 2020;160:105184. [PMID: 32946931 DOI: 10.1016/j.phrs.2020.105184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Liu Y, Lv X, Xia S, Hao B, Huang X, Shi P. PEGylated graphene oxide as a nanocarrier of the disulfide prodrug of podophyllotoxin for cancer therapy. J Nanopart Res 2020;22. [DOI: 10.1007/s11051-020-05003-5] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Fattahi N, Shahbazi MA, Maleki A, Hamidi M, Ramazani A, Santos HA. Emerging insights on drug delivery by fatty acid mediated synthesis of lipophilic prodrugs as novel nanomedicines. J Control Release 2020;326:556-98. [PMID: 32726650 DOI: 10.1016/j.jconrel.2020.07.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
11 Wang W, Fan J, Zhu G, Wang J, Qian Y, Li H, Ju J, Shan L. Targeted Prodrug-Based Self-Assembled Nanoparticles for Cancer Therapy. Int J Nanomedicine 2020;15:2921-33. [PMID: 32425524 DOI: 10.2147/IJN.S247443] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]